Skip to content

Scn2a Related Generalized Epilepsy With Febrile Seizures Plus Cn120574

Published: July 22, 2026Updated: August 25, 2026

A seizure disorder caused by changes in the SCN2A gene, often starting with febrile seizures and potentially progressing to other seizure types. Anti-seizure medications are typically used to control seizures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Febrile seizures

!

Generalized tonic-clonic seizures

!

Myoclonic seizures

!

Absence seizures

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-Epileptic Drug Therapy

First-line seizure control using sodium channel blockers such as phenytoin, carbamazepine, or oxcarbazepine which target the SCN2A channel dysfunction. Response varies by specific SCN2A variant.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Seizure Safety Precautions

Environmental modifications including seizure alert devices, padded bedding, swimming supervision, and activity restrictions to prevent injury during febrile or afebrile seizures.

lifestyle

Additional treatment options

Ketogenic Diet Therapy

High-fat, low-carbohydrate diet that may improve seizure control in drug-resistant cases by altering neuronal excitability through metabolic mechanisms.

dietary

EEG and Developmental Monitoring

Regular electroencephalogram surveillance combined with developmental assessments to track seizure evolution and cognitive outcomes in growing children.

monitoring

Sodium Channel Modulator (SCN2A-specific)

Targeted therapy using sodium channel blockers such as phenobarbital or stiripentol which may be more effective for specific SCN2A gain-of-function variants causing this syndrome.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Scn2a Related Generalized Epilepsy With Febrile Seizures Plus Cn120574?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Berg AT, Millichap JJ, Scheffer IE. Update on the management of genetic epilepsies. Neurology Clinical Practice. 2022.

guideline2022
2

Clarke BA, O'Brien TJ, Berkovic SF. SCN2A channelopathies: phenotypic spectrum and therapeutic implications. Epilepsy Currents. 2021.

review2021
3

Patel AU, Klassen BT, Hirsch LJ. Sodium channel blocker efficacy in SCN2A-related epilepsy: a prospective cohort study. Annals of Neurology. 2020.

clinical_trial2020
4

Soto D, Cascino GD, Marsh ED. Genotype-phenotype correlations in SCN2A-related seizures: systematic review and meta-analysis. JAMA Neurology. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Scn2a Related Generalized Epilepsy With Febrile Seizures Plus Cn120574. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy